Logo FCSQ English

Anne-Marie Mes-Masson, Ph. D.

Share

Share on social media

Anne-Marie Mes-Masson, Ph. D.
Anne-Marie Mes-Masson, Ph. D. Full Professor Department of Medicine, Université de Montréal, Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM)

Bio

  • Scientific Director, Montreal Cancer Institute
  • Director, FRQS Cancer Research Network

A molecular biologist renowned for her work in fundamental and translational research in cancerology. Dr. Mes-Masson’s works focus on the development of cancer models and the identification of molecular events associated with the cancer. Dr. Anne-Marie Mes-Masson uses cutting-edge genomic technologies to determine the characteristics of the molecular events associated with certain cancers. She is also a pioneer in tumour banking practices, including the breast cancer bank supported by the Quebec Breast Cancer Foundation. She also developed expertise in molecular pathology and the use of bio-banked specimens to probe the importance of various biomarkers.

Why Choosing Breast Cancer?

Dr. Mes-Masson has developed key partnerships in the field of hereditary cancers, including breast cancer.  

A Scientific Accomplishment You Are Proud of

"Regarding scientific breakthroughs, I am proud to have contributed to the works that made it possible to identify mutations in the BRCA1/BRCA2 genes that are peculiar to French-Canadian families. My contribution was essential to the efforts of the Cancer Network, and its partner the QBCF, in mobilizing the four faculties of medicine in Quebec to achieve a unified collective strategy for bio-banking breast cancer specimens used in research.”

Research Focus

  • Cancer biology
  • Etiology (causes)
  • Prevention
  • Screening, diagnosis or prognosis
  • Treatments
  • Development of scientific models

Distinctions

2013 – The Karen Campbell National Award for Research Excellence

Projects Funded by the Foundation

2011 – Tissue and data bank – Cancer Research Network

2014 – The Quebec Breast Cancer Foundation Tissue Microarrays Consortium for the Evaluation of biomarkers